Breast cancer AI wins CE certification

The European Union has certified AI software for reading mammograms, clearing the way for a South Korea-based AI vendor to sell another of its AI products across the European Economic Area.

Seoul-based Lunit announced the CE certification of its Insight MMG product June 2.

The announcement cites a study recently published in Lancet Digital Health showing the software outperformed breast-cancer specialists when the humans worked alone and even when they were aided by AI.

Last fall Lunit gained CE certification for its AI-based chest x-ray solution.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.